John Soloninka
Amministratore Delegato presso Baton Pharma, Inc.
Profilo
John Soloninka is currently the Chief Executive Officer & Director at Baton Pharma, Inc. and the Chief Operating Officer at SpinaFX Medical, Inc. He previously held positions as the President & Chief Executive Officer at The Health Technology Exchange, Co-Chairman-Ontario Brain Innovation Council at Ontario Brain Institute, Director at Baycrest, Director at Centre For Imaging Technology Commercialization, Director at Mars Excite, and Senior Vice President-Acquisitions & Exits at Scryb, Inc. Mr. Soloninka received his undergraduate degree from Queen's University in 1981 and his MBA degree from the University of London in 1986.
Posizioni attive di John Soloninka
| Società | Posizione | Inizio |
|---|---|---|
Baton Pharma, Inc.
 Baton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Baton Pharma, Inc. engages in a pharmaceutical company. It focuses on chronic disease and acute recurring medical conditions. The company is headquartered in Toronto, Canada. | Amministratore Delegato | - |
| SpinaFX Medical, Inc. | Direttore operativo | 01/10/2021 |
Precedenti posizioni note di John Soloninka
| Società | Posizione | Fine |
|---|---|---|
| Mars Excite | Direttore/Membro del Consiglio | - |
| SCRYB INC. | Corporate Officer/Principal | - |
Centre For Imaging Technology Commercialization
 Centre For Imaging Technology Commercialization Packaged SoftwareTechnology Services Centre For Imaging Technology Commercialization medical technology manufacturer. The company is headquartered in London, Canada. | Direttore/Membro del Consiglio | - |
Ontario Brain Institute
 Ontario Brain Institute Medical/Nursing ServicesHealth Services Ontario Brain Institute engages in the provision on neuroscience research. It provides enhance neuroscience research system, for the Ontario neurotechnology cluster, and improve brain health. The company was founded by Joseph L. Rotman and Sandra Rotman and is headquartered in Toronto, ON. | Corporate Officer/Principal | - |
| Baycrest | Direttore/Membro del Consiglio | - |
Formazione di John Soloninka
| Queen's University | Undergraduate Degree |
| University of London | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SCRYB INC. | Technology Services |
| Aziende private | 7 |
|---|---|
| Baycrest | |
The Health Technology Exchange
 The Health Technology Exchange Financial ConglomeratesFinance The Health Technology Exchange provides non-dilutive project financing to the medical and assistive technology sector. The company’s programs include Health Technology Commercialization Program (HTCP), REACH Innovation Procurement program and MedTech ecosystem support activities. Its initiatives include The Harmony Project, The HTX Soft Landing Program and Medtech RISE. The company was founded in 2004 and is headquartered in Toronto, Canada. | Finance |
Ontario Brain Institute
Ontario Brain Institute Medical/Nursing ServicesHealth Services Ontario Brain Institute engages in the provision on neuroscience research. It provides enhance neuroscience research system, for the Ontario neurotechnology cluster, and improve brain health. The company was founded by Joseph L. Rotman and Sandra Rotman and is headquartered in Toronto, ON. | Health Services |
Centre For Imaging Technology Commercialization
Centre For Imaging Technology Commercialization Packaged SoftwareTechnology Services Centre For Imaging Technology Commercialization medical technology manufacturer. The company is headquartered in London, Canada. | Technology Services |
| Mars Excite | |
Baton Pharma, Inc.
Baton Pharma, Inc. Pharmaceuticals: MajorHealth Technology Baton Pharma, Inc. engages in a pharmaceutical company. It focuses on chronic disease and acute recurring medical conditions. The company is headquartered in Toronto, Canada. | Health Technology |
| SpinaFX Medical, Inc. |
- Borsa valori
- Insiders
- John Soloninka
